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Summary. Background. Liposomal magnetofection is based on the use of superparamagnetic 
particles and cationic lipids and shows better transfection efficiency than other common nonviral 
gene delivery methods; however, the distribution of aggregate complexes over the cell surface may 
be ununiform. The use of a dynamic gradient magnetic field could overcome this limitation. A 
newly developed device for magnetofection under a dynamic magnetic field was used to compare 
the transfection efficiency of prostate carcinoma cell line PC3 with that obtained by lipofection and 
magnetofection. 
Material and Methods. Reporter plasmid pcDNA3.1LacZ DNA was used in combination with 
Lipofectamine2000 reagent and superparamagnetic nanoparticles CombiMag. The effects of in-
cubation time under a dynamic magnetic field and a rotation frequency of magnets on transfection 
efficiency for PC3 cell line were determined. Alternatively, lipofection and liposomal magnetofec-
tion were carried out. Transfection efficiency of delivery methods was estimated by β-galactosidase 
staining; cell viability, by acridine orange/ethidium bromide staining.
Results. Liposomal magnetofection under a dynamic gradient magnetic field demonstrated the 
highest transfection efficiency: it was greater by almost 21% and 42% in comparison with liposomal 
magnetofection and lipofection, respectively. The optimal incubation time under dynamic magnetic 
field and the optimal magnet rotation frequency were 5 minutes and 5 rpm, respectively. Liposomal 
magnetofection under a dynamic gradient magnetic field was less cytotoxic (7%) than that under a 
permanent magnetic field (17%) and lipofection (11%). 
Conclusions. Our new approach, based on the use of a dynamic gradient magnetic field, en-
hanced the transfection efficiency and had a less cytotoxic effect on prostate cancer cells in compari-
son with the standard magnetofection and lipofection. 
Introduction
Efficient DNA and siRNA transfection is a 
critical factor for the development of new clinical 
therapy. Since the first reports on the introduction 
of foreign genetic material into cultured cells by 
cationic polymers, a substantial progress in non-
viral gene delivery has been achieved (1, 2). Cur-
rently, cationic lipids that allow maximizing DNA 
complexation and membrane fusion have become 
widely used delivery agents among nonviral deliv-
ery systems (3). The association of the lipid-based 
transfection reagent with nucleic acids results in a 
tight compaction and protection of nucleic acids, 
and these cationic complexes are mainly internal-
ized by endocytosis (3, 4). The main advantages of 
lipofection are its high efficiency, ability to trans-
fect all types of nucleic acids in a wide range of cell 
types, ease of use, reproducibility, and low toxicity 
(5, 6). Nevertheless, an insufficient contact of this 
delivery system with target cells is one of the main 
reasons for their often observed limited efficiency 
(7). A novel method exploring a permanent mag-
netic field acting on nucleic acid vectors associated 
with magnetic particles in order to mediate a rapid 
contact of vectors with target cells was described in 
2000 by Luo and Saltzman (8). Using this method, 
termed magnetofection, magnetic particles contain-
ing nucleic acids are sedimented onto the surface 
of cells within minutes overcoming a diffusion bar-
rier by this way. This process leads to a considerable 
improvement in transfection efficiency compared 
with transfection carried out by biochemical meth-
ods (e.g., lipofection) (9–12). Further enhancement 
of magnetofection efficiency has been achieved by 
the application of a pulsed magnetic field in which 
alternating horizontal, perpendicular, and oscil-
lating movements of the magnetic particles are 
induced (13, 14). Recently, the method of liposo-
mal magnetofection, which combines biochemical 
and physical delivery systems of nucleic acids, has 
been reported (15–18). In this technique, the self-
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assembled complexes of enhancers such as cationic 
lipids with nucleic acids and magnetic nanoparticles 
are formed and then concentrated on the surface 
of cells by applying a permanent magnetic field. 
Magnetofection and liposomal magnetofection have 
been successfully used in in vitro applications for 
various types of nucleic acids and across a broad 
range of cell lines (15–22). Nevertheless, there is a 
continued need for further improvements in terms 
of transfection efficiency. Here we report a new ap-
proach, based on the application of a dynamic gradi-
ent magnetic field, which enhances gene delivery in 
prostate cancer cells. 
Material and Methods
Materials
CombiMag magnetic nanoparticles were ob-
tained from Chemicell GmbH. They are composed 
of magnetite (Fe3O4) and are 100 nm in hydrody-
namic diameter on the average. Cylindrical rare-
earth neodymium-iron-boron (NdFeB) N38 grade 
1.26-T induction magnets were purchased from 
Semicom Ltd. Lipofectamine2000, a transfection 
reagent, was purchased from Invitrogen Corp.
Cell Line
Human prostate cancer cell line PC3 was grown 
in RPMI-1640 culture medium supplemented with 
10% fetal bovine serum (Invitrogen Corp.), penicil-
lin (100 U/mL), and streptomycin (100 μg/mL) (In-
vitrogen Corp.). The cell line was cultured at 37°C 
in a humidified incubator supplied with 5% CO2.
Plasmid Preparation
The competent Escherichia coli XL1Blue strain 
(Promega Corp.) was transformed by pcDNA3.1LacZ 
(Invitrogen Corp.) according to the standard pro-
tocol. Bacterial cells were cultured under optimal 
conditions (37°C, 200 rpm) overnight, and the plas-
mid vector was purified using a Plasmid Midi kit 
(QIAGEN GmbH) according to the manufacturer’s 
protocol. Plasmid DNA concentration was detected 
by a NanoDrop spectrophotometer (Thermo Fisher 
Scientific Inc.). 
Transfection and Exposure to Magnetic Field
PC3 cells were seeded in 24-well plates at a 
density of 1.8×105 per well one day before trans-
fection to obtain 80% confluence. All incubations 
were performed at 37oC and 5% CO2. Before trans-
fection, the growth medium was removed, and 
350 μL of Opti-MEM reduced serum medium (In-
vitrogen Corp.) was added. The expression vector 
pcDNA3.1LacZ encoding beta-galactosidase was 
used to evaluate the transfection efficiency of the 
PC3 cell line. The samples were prepared in trip-
licate. Lipofectamine2000 (Invitrogen Corp.) was 
used to transfect the cell line based on the manufac-
turer’s recommendations. 
For the transfection of PC3 cells, 2 μL of Lipo-
fectamine2000, 1 μg of pcDNA3.1LacZ, and an 
equal volume (1 μL) of CombiMag magnetic nano-
particles (Chemicell GmbH) were diluted separately 
in 50 μL of Opti-MEM reduced serum medium 
and mixed gently. After the 5-minute incubation at 
room temperature, CombiMag, Lipofectamine2000, 
and pcDNA3.1LacZ were combined; the mixture 
was gently pipetted up and down and incubated for 
additional 25 minutes at room temperature to allow 
the plasmid-CombiMag-Lipofectamine2000 com-
plexes to form. Subsequently, 150 μL of the com-
plexes was added to each well, and the cell culture 
plates were placed either on an NdFeB permanent 
magnet or incubated on a dynamic magnetic field de-
vice “DynaFECTOR” for 5, 10, and 20 minutes with a 
specified magnet rotation frequency of 5, 25, 50, and 
100 rpm. Alternatively, lipofection was carried out. 
For liposome formation, 2 μL of Lipofectamine2000 
and 1 μg of pcDNA3.1LacZ were diluted separately 
in 75 μL of Opti-MEM reduced serum medium and 
mixed gently. After the 5-minute incubation at room 
temperature, Lipofectamine2000 and pcDNA3.1LacZ 
were combined; the mixture was gently pipetted 
up and down and incubated for additional 25 min-
utes at room temperature to allow the plasmid-Lipo-
fectamine2000 complexes to form. After the incuba-
tion, 150 μL of the complexes was added to each well, 
and the plate was placed into a CO2 incubator for 24 
hours; no magnetic field was applied for lipofection. 
Determination of LacZ Gene Expression
After the 24-hour incubation, LacZ gene expres-
sion was detected using a b-Gal staining kit (Invit-
rogen Corp.) according to the manufacturer’s pro-
tocol. Transfection efficiency was determined by 
counting stained and unstained cells under a micro-
scope and calculating the percentage of stained cells 
in the total population. The untransfected cells were 
included to account for a background.
Analysis of Cell Viability
Cell viability was determined using ethidium 
bromide/acridine orange (EB/AO) staining as de-
scribed by Ribble et al. (23). For analysis, cells were 
cultivated on cover slips in 24-well plates. Twenty-
four hours after the transfection, the cells were gen-
tly washed with 1 mL of cold PBS, and the EB/AO 
dye mix containing 10 µg/mL of each dye was add-
ed to the cells. The number of viable (green) and 
dead (yellow/red) cells was counted using a Nikon 
microscope at a magnification of ×400 with an exci-
tation filter. Pictures were taken with a Nikon digital 
camera. The tests were done in triplicate counting a 
minimum of 100 total cells. 




Device Construction and Methodology
For the creation of a dynamic magnetic field, 
the rotating property of an orbital shaker was used. 
Instead of a platform shaker, the magnetic system 
of cylindrical permanent magnets with a saturation 
induction of 1.33 T arranged in a checkerboard pat-
tern unipolarly was inserted as shown in Fig. 1. A 
24-well plate was located on a nonmagnetic metal 
surface over a magnet system. The distance from 
the bottom of the plates to the upper surface of the 
magnets was fixed and was 3.5 mm. Electronics 
provided a programmable rotation of the magnetic 
system on the orbit at a given speed of 1–150 rpm 
for a fixed time of 1 to 999 minutes. In addition, the 
direction of rotation was reversed after 30 seconds. 
The magnets were inserted in such a way that in 
view of their movement, it was possible to reach a 
magnetic field of 0.35 T and normal and tangential 
gradients of 3×107 A/m2 according to the computer 
modeling of magnetic vector force. Fig. 2 demon-
strates that during the magnet rotation, every mag-
netic particle crosses the magnet edges twice.
Optimal Conditions for Magnetofection 
in a Dynamic Gradient Magnetic Field 
To determine the optimal exposure time to 
a dynamic gradient magnetic field, the plasmid-
Lipo fectamine2000-CombiMag complexes were 
incubated on the “DynaFECTOR” for 5, 10, and 
20 minutes with a magnet rotation frequency of 
5 rpm. Exposure to a dynamic gradient magnetic 
field for 5, 10, and 20 minutes resulted in a trans-
fection efficiency of 77.7%±1.5%, 56.0%±2.6%, and 
43.0%±3.6%, respectively (Fig. 3). The 5-minute 
exposure, which demonstrated the highest transfec-
tion efficiency, was further used to study the mag-
netically driven DNA delivery using various magnet 
rotation frequencies. The exposure of PC3 cells to 
the permanent magnetic field for 5, 10, and 20 min-
utes gave a transfection efficiency of 56.7%±4.0%, 
47.2%±4.0%, and 39.1%±5.0%, respectively (data 
not shown). The highest transfection efficiency was 
also obtained by using 5-minute exposure to a per-
manent magnetic field.
In order to find out an optimal magnet rotation 
frequency for a dynamic gradient magnetic field, 
the plasmid-Lipofectamine2000-CombiMag com-
plexes were incubated on the “DynaFECTOR” for 
5 minutes with a magnet rotation frequency of 5, 
25, 50, and 100 rpm. The variation of magnet ro-
tation frequency resulted in the following transfec-
tion efficiency: 77.7%±1.5% (5 rpm), 44.7%±1.5% 
(25 rpm), 38.7%±1.5% (50 rpm), and 51.7%±1.5% 
(100 rpm) (Fig. 4). 
Enhancment of Transfection Efficiency by a 
Dynamic Gradient Magnetic Field 
The obtained results from PC3 cells exposed to 
a dynamic gradient and permanent magnetic field, 
and cells not exposed to a magnetic field, e.g., trans-
fected by lipofection, are presented in Fig. 5. The 
highest transfection efficiency reaching 79% was 
achieved using a dynamic gradient magnetic field 
with the optimal parameters. It was greater by 21% 
and 42% as compared with liposomal magnetofec-
tion and lipofection, respectively. 
Application of Dynamic Gradient 
Magnetic Field is Less Cytotoxic to Cells 
To estimate the effect of a dynamic gradient 
magnetic field on cell viability, AO/EB staining of 
PC3 cells following liposomal magnetofection under 
permanent and dynamic gradient magnetic fields 
and lipofection was carried out. As shown in Fig. 6, 
the viability of PC3 cells magnetofected under a 
dynamic gradient magnetic field was higher (93%) 
than that of cells under a permanent magnetic field 
(83%) and traditional lipofection (89%). Therefore, 
the pDNA delivery into PC3 cells using a dynamic 
gradient magnetic field not only enhanced transfec-
tion efficiency, but also reduced cytotoxicity. 
Discussion
In this study, an improved plasmid DNA delivery 
method based on the application of dynamic gra-
Fig. 1. Magnetic system of cylindrical permanent magnets 
arranged in a checkerboard pattern
Fig. 2. Schematic illustration of the part of magnetic system 
for the magnetofection and magnetic force direction under 
the dynamic gradient magnetic field
F, tangential component of magnetic field acting on magne-
toplexes in a direction indicated by the arrow. a, b, c, and d, 
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Fig. 3. Dependence of liposomal magnetofection on the 
duration of exposure to a dynamic gradient magnetic field 
A, representative data show β-galactosidase expression in PC3 
cells 24 hours after liposomal magnetofection using 5- (1), 10- 
(2), and 20-minute (3) exposure to a dynamic magnetic field; 
B, bar chart shows the proportion of transfected cells 24 hours 
after 5-, 10-, and 20-minute exposure to a dynamic gradient 
magnetic field. Data represent the mean values 























Fig. 4. The effect of magnet rotation frequency 
on the expression of β-galactosidase 
A, representative data show β-galactosidase expression in PC3 
cells 24 hours after liposomal magnetofection under a dynamic 
magnetic field with a magnet rotation frequency of 5 (1), 25 (2), 
50 (3), and 100 (4) rpm; B, bar chart shows the proportion of 
transfected cells 24 hours after liposomal magnetofection un-
der a dynamic magnetic field with a magnet rotation frequency 
of 5, 25, 50, and 100 rpm. Data represent the mean values of 
3 independent experiments.
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Fig. 5.  The effect of different gene delivery methods on the 
transfection efficiency of PC3 cells by pcDNA3.1LacZ plasmid
A, representative data show β-galactosidase expression in PC3 
cells 24 hours after lipofection (1), liposomal magnetofection 
(2), and liposomal magnetofection under a dynamic magnetic 
field (3); B, bar chart shows the proportion of transfected cells 
24 hours after lipofection (L), liposomal magnetofection (LM), 
and liposomal magnetofection under a dynamic magnetic field 
(LMuDMF). Data represent the mean values of 3 independent 
experiments.
Fig. 6. Cytotoxicity of different gene delivery methods
A, representative data of AO/EB staining of PC3 cells 24 
hours following lipofection (1), liposomal magnetofection (2), 
and liposomal magnetofection under a dynamic magnetic field 
(3); B, cytotoxicity (cell viability) following lipofection (1), 
liposomal magnetofection (2), and liposomal magnetofection 
under a dynamic magnetic field (3).
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dient magnetic field, which enhances the nonviral 
gene delivery to prostate cancer cells, is described. 
The presence of a permanent magnetic field for 5 
minutes is sufficient to significantly increase trans-
fection efficiency over lipofection. 
Our findings are consistent with the results of 
previous studies, which demonstrated that the per-
manent magnetic field enhanced transfection ef-
ficiency (13, 19). However, despite the promising 
results showing a high gene transfer rate, the perma-
nent magnetic field has one disadvantage associated 
with a nonuniform distribution of complexes over 
the cell surface. To overcome this limitation, the de-
vice “DynaFECTOR” with an orbital rotation of cy-
lindrical permanent magnets was constructed. The 
part of magnetic system consisting of 1 cylindrical 
permanent magnet and 2 wells of plate as shown in 
Fig. 2 illustrates the principle of our device. When 
the moving magnet is in the position (b) as shown in 
the same figure, the tangential component of mag-
netic force (F) directed to the center of the magnet 
starts attracting of magnetoplexes to the edge of the 
well. After the magnet reaches the position (c), the 
magnetoplexes are attracted to the opposite edge of 
the well doing displacements of magnetoplexes in 
parallel to the bottom of the well. Under prolonged 
rotation, magnetoplexes are pulled down to the bot-
tom of the wells and make multiple displacements 
along the cell surface.
We hypothesize that the dynamic gradient mag-
netic field provides a more uniform distribution of 
complexes as well as a more efficient cellular up-
take of cationic lipid/nucleic acid complexes with 
magnetic nanoparticles. This magnetic field forces 
cationic lipid/nucleic acid complexes with magnetic 
nanoparticles oscillate not only perpendicularly, 
concentrating the complexes on the surface of cells, 
but also parallel to the cell surface that leads to a slow 
rolling of the complexes over the surface of cells, 
facilitating the cellular uptake. Our results indicate 
that the efficiency of liposomal magnetofection in 
the presence of a dynamic magnetic field depends 
on the exposure time and magnet rotation frequen-
cy. Time dependency of transfection efficiency us-
ing a magnetic field is also reported previously by 
Kamau et al. (13). For human prostate cancer cells, 
the highest transfection efficiency exceeding that of 
standard magnetofection has been achieved in the 
presence of a dynamic magnetic field for 5 minutes 
with a magnet rotation frequency of 5 rpm. 
The cytotoxicity of a dynamic magnetic field is 
lower than that of other delivery methods applied in 
our study. Because of orbital magnet rotation, the 
force of a magnetic field during the 5-minute in-
cubation all the time is changed. We suppose that 
this alteration of magnetic force prevents from large 
aggregates and chain-like structure formation onto 
cell membranes decreasing cell damage and, conse-
quently, cytotoxicity by this mean.
Magnetofection of reporter genes in vivo was 
performed in several studies using rats, mice, and 
pigs, and the feasibility of this technology has been 
demonstrated (14, 25). The same approach has also 
been used in few clinical trials (14, 24, 25). The 
technology uses an externally positioned magnet to 
create a localized magnetic field within the body, 
and the physical force created by the magnetic field 
draws the therapeutic genes/drugs through the arte-
riole into the targeted area. We think that using the 
same technology, the dynamic magnetic field also 
could be applicable for targeted delivery of a gene/
drug in vivo, and further studies in an animal model 
are planned. 
In summary, the obtained results strongly sup-
port the use of a dynamic gradient magnetic field 
as a perspective tool for nonviral gene delivery into 
malignant cells. 
Conclusions
The magnetofection efficiency obtained by using 
“DynaFECTOR” was higher than that of lipofection 
and standard magnetofection in all performed ex-
periments. The dynamic gradient magnetic field was 
found to be able to enhance the delivery of nucleic 
acids into prostate cancer cells with a reduced cyto-
toxicity. To confirm a universality of this approach, 
further studies using cell lines of various origins are 
required. In the future, the use of “DynaFECTOR” 
for such a bioapplication as shRNA coding plasmid 
screening for the drug therapy can undoubtedly 
have the advantage for successful results. 
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